A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
Public ClinicalTrials.gov record NCT01987427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01987427
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Eisai Inc.
- Industry
- Enrollment
- 344 participants
Conditions and interventions
Conditions
Interventions
- lorcaserin + phentermine placebo Drug
- lorcaserin + phentermine-HCl Drug
- lorcaserin + phentermine-HCl + phentermine placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2013
- Primary completion
- Jul 31, 2014
- Completion
- Sep 2, 2014
- Last update posted
- Sep 29, 2019
2013 – 2014
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Radiant Research - Arizona | Chandler | Arizona | 85224 | — |
| Scripps Clinical Research Center | La Jolla | California | 92037 | — |
| Translational Research Institute for Metabolism and Diabetes | Orlando | Florida | 32804 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Boston Medical Center | Boston | Massachusetts | — | — |
| Weill Cornell College | New York | New York | 10065 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Radiant Research - Columbus | Columbus | Ohio | 43212 | — |
| Radiant Research - South Carolina | Anderson | South Carolina | 29621 | — |
| Radiant Research - Dallas | Dallas | Texas | 75231 | — |
| National Clinical Research - Norfolk | Norfolk | Virginia | 23502 | — |
| National Clinical Research - Richmond | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01987427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2019 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01987427 live on ClinicalTrials.gov.